“…In addition, metabolism enzymes, transport proteins, cell membrane permeability, and gut microbiota are easily altered under pathological states, thereby affecting the absorption, distribution, metabolism, and excretion of the medical supplements and influencing their efficacy. 18–20 Interestingly, we found that the pharmacokinetic behaviors of the above compounds in the CUMS rats differed from those in normal rats after CDE and CTE administration. The relative bioavailability of the most absorbed compounds of CH under a depression-like state was generally higher, which are related with the pathological conditions in depressed rats, such as enhanced intestinal epithelial permeability, 21 gut microbiota dysfunction, 22 and CYP450 activity alternation, 23 but the specific mechanism remains to be further explored.…”